Analyst Maintains 'Outperform' for Nutrien (NYSE:NTR) Amidst Strategic Shifts

• CIBC maintained an "Outperform" rating for Nutrien, though it slightly lowered its price target to $84.00 from $85.00.
• Nutrien reported strong financial performance with a second-quarter adjusted EBITDA of $2.40 billion and revenues of $10.81 billion, despite an EPS of $2.61 missing analyst estimates.
• The agricultural giant is implementing strategic adjustments, including an increased 2026 potash sales-volume forecast and plans for share buybacks.

Nutrien (NYSE:NTR) is a major global producer of agricultural products and services. The company primarily produces and distributes potash, nitrogen, and phosphate fertilizers for farmers worldwide. It operates a large retail network that provides crop nutrients, crop protection products, seeds, and other essential services directly to growers, solidifying its position as a leading fertilizer producer.

On August 10, 2026, analyst firm CIBC maintained its "Outperform" rating for Nutrien. This positive analyst rating suggests that CIBC expects the stock to perform better than the overall market. However, the firm adjusted its price target, lowering it to $84.00 from $85.00. At the time of this update, the stock was trading at $64.98, reflecting current market sentiment and investment outlook.

The positive outlook for Nutrien is supported by strong financial performance. Nutrien reported a second-quarter adjusted EBITDA of $2.40 billion and a first-half adjusted EBITDA of $3.50 billion. Adjusted EBITDA is a key measure of a company's operational profitability before interest, taxes, depreciation, and amortization are deducted, giving a clearer view of core business performance and financial results.

Despite strong revenues of $10.81 billion for the quarter, the company's earnings per share (EPS) of $2.61 missed the Zacks Consensus Estimate of $2.70. EPS represents the portion of a company's profit allocated to each share of stock. This slight miss in EPS may have contributed to the modest reduction in CIBC's price target, influencing the stock analysis.

In response to evolving market conditions, Nutrien is making strategic adjustments to its operations. The company raised its 2026 potash sales-volume forecast to a range of 14.2 million to 14.8 million tons. It also plans to reduce its capital spending and increase the rate at which it buys back its own shares, demonstrating a proactive market strategy to enhance shareholder value.